Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
Completed · Phase 4
Conditions studied: Von Willebrand Disease, Blood Coagulation Disorders, Blood Platelet Disorders, Hematologic Disease
In brief
The purpose of this study is to test the safety and effectiveness of Humate-P® to prevent bleeding in patients with von Willebrand Disease who are undergoing surgery.
Key facts
- Study ID
- NCT00168090
- Run by
- CSL Behring
- People needed
- 30
- Starts
- 2001-10-01
- Expected to finish
- 2006-05-01
- Last updated by the study team
- 2011-02-11
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.